Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2025-12-26 @ 3:15 AM
Study NCT ID:
NCT01132820
Status:
COMPLETED
Last Update Posted:
2019-08-08
First Post:
2010-05-27
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06
Start Date Type:
None
Primary Completion Date:
2016-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-01
Completion Date Type:
ACTUAL
First Submit Date:
2010-05-27
First Submit QC Date:
None
Study First Post Date:
2010-05-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-15
Results First Submit QC Date:
None
Results First Post Date:
2017-08-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-06
Last Update Post Date:
2019-08-08
Last Update Post Date Type:
ACTUAL